vimarsana.com
Home
Live Updates
A Look at FDA's Proposed Changes to Labeling for Biosimilars
A Look at FDA's Proposed Changes to Labeling for Biosimilars
A Look at FDA's Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars | Foley & Lardner LLP
The labeling of biosimilar products as “interchangeable” may be important in order to gain acceptance and use in the medical community. This article provides important information...
Related Keywords
,
Public Health ,
Additional Draftq As On Biosimilar Development ,
Service Act ,
Drug Administration ,
Interchangeable Biosimilar Products ,
Biosimilar Development ,
Changes Included ,
Register Notice ,
Prescribing Information ,